IL159311A0 - Remedies for diseases caused by nonsense mutation - Google Patents

Remedies for diseases caused by nonsense mutation

Info

Publication number
IL159311A0
IL159311A0 IL15931102A IL15931102A IL159311A0 IL 159311 A0 IL159311 A0 IL 159311A0 IL 15931102 A IL15931102 A IL 15931102A IL 15931102 A IL15931102 A IL 15931102A IL 159311 A0 IL159311 A0 IL 159311A0
Authority
IL
Israel
Prior art keywords
remedies
diseases caused
nonsense mutation
nonsense
mutation
Prior art date
Application number
IL15931102A
Other languages
English (en)
Inventor
Masayuki Arakawa
Ryoichi Matsuda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of IL159311A0 publication Critical patent/IL159311A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A61K31/175—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine having the group, >N—C(O)—N=N— or, e.g. carbonohydrazides, carbazones, semicarbazides, semicarbazones; Thioanalogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL15931102A 2001-06-13 2002-06-13 Remedies for diseases caused by nonsense mutation IL159311A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29753301P 2001-06-13 2001-06-13
PCT/JP2002/005914 WO2002102361A1 (fr) 2001-06-13 2002-06-13 Remedes a des maladies provoquees par une mutation non-sens

Publications (1)

Publication Number Publication Date
IL159311A0 true IL159311A0 (en) 2004-06-01

Family

ID=23146711

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15931102A IL159311A0 (en) 2001-06-13 2002-06-13 Remedies for diseases caused by nonsense mutation

Country Status (6)

Country Link
US (1) US20050014835A1 (ja)
EP (1) EP1402889A1 (ja)
JP (1) JPWO2002102361A1 (ja)
CA (1) CA2449950A1 (ja)
IL (1) IL159311A0 (ja)
WO (1) WO2002102361A1 (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8870655B2 (en) * 2005-08-24 2014-10-28 Nintendo Co., Ltd. Wireless game controllers
GB0525492D0 (en) * 2005-12-15 2006-01-25 Univ Dundee Filaggrin
GB0600948D0 (en) 2006-01-18 2006-02-22 Univ Dundee Prevention/Treatment Of Ichthyosis Vulgaris, Atopy And Other Disorders
EP2047848A4 (en) * 2006-07-05 2010-06-09 Univ Tokyo METHOD FOR THE TREATMENT OF GENETIC DISEASES BASED ON A NONSENSE MUTATION
RU2571060C2 (ru) 2010-02-03 2015-12-20 Майкробайл Кемистри Рисерч Фаундейшн Индуктор считывания и терапевтический агент для генетических заболеваний, вызванных мутациями типа нонсенс-мутаций
JP6288911B2 (ja) 2011-12-01 2018-03-07 学校法人東京薬科大学 リードスルー活性を有する化合物
CN107129440B (zh) * 2017-06-20 2018-12-04 上海应用技术大学 一种天然产物(+)-负霉素的全合成方法
US20230203482A1 (en) 2017-11-02 2023-06-29 The Wistar Institute Of Anatomy And Biology Methods of Rescuing Stop Codons via Genetic Reassignment with ACE-tRNA

Also Published As

Publication number Publication date
JPWO2002102361A1 (ja) 2004-09-30
US20050014835A1 (en) 2005-01-20
WO2002102361A1 (fr) 2002-12-27
CA2449950A1 (en) 2002-12-27
EP1402889A1 (en) 2004-03-31

Similar Documents

Publication Publication Date Title
HK1062408A1 (en) Remedies for infant chronic arthritis-relating diseases
HUP0303622A3 (en) Emedies for inflammatory bowel diseases
AU2002243032A1 (en) Remdies for infant chronic arthritis-relating diseases
EP1555018A4 (en) MEANS FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES
IL159344A0 (en) Quinuclidines-substituted-multicyclic-heteroaryls for the treatment of disease
AU2002353378A8 (en) Vaccine for periodontal disease
EP1449542A4 (en) GENETIC AGENTS FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES
AU8622101A (en) Remedies for ischemic diseases
AU2000279614A1 (en) Remedies for endothelin-induced diseases
AU2000265525A1 (en) Medicament for treating intestinal diseases
IL159311A0 (en) Remedies for diseases caused by nonsense mutation
AU2002365093A8 (en) Therapeutic compositions
IL159478A0 (en) Remedies for eosinophilic diseases
AU2002315848A1 (en) Remedies for eosinophilic diseases
EP1444983A4 (en) AGENTS FOR THE TREATMENT OF INFLAMMATORY ABDOMINAL DISEASES
EP1411119A4 (en) METHOD FOR BUILDING A MUTANT
EP1393740A4 (en) NEW MEANS FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES
IL160852A0 (en) Pharmaceutical compositions for the treatment of urinary disorders
GB0109428D0 (en) Therapeutic compositions
EP1252895A4 (en) REMEDIES FOR OPHTHALMIC DISORDERS
EP1304117A4 (en) MEDIUM FOR BONE DISEASES
EP1426762A4 (en) DRUGS FOR CARDIAC DISEASES
GB0128628D0 (en) Disease treatment
AU2002313217A1 (en) Agents for Treating Diseases Caused by Nonsense Mutations
EP1386919A4 (en) REMEDIES